CONOLIDINE SECRETS

Existing workflows employed for determining the MOA of novel compounds normally involve an assortment of useful screening assays incorporating a myriad of isolated biological targets. These procedures typically tend not to document operate inside the dynamic environment where these targets usually reside. This is particularly essential for ion chan